[1]
M. A. Abualsaud, “Tirzepatide in Type 2 Diabetes Mellitus: A Comprehensive Review of Its Novel Dual GIP/GLP-1 Receptor Agonism, Clinical Efficacy, Safety, and Therapeutic Potential”, IJASIS, pp. 31–39, Oct. 2026, doi: 10.29284/x84kd674.